Table 2. Outcome measures after 2 weeks of treatment and the follow up of 12 weeks.
| Outcomes | Groups | Baseline | Short-term effectiveness (after 2 weeks of treatment) |
Long-term effectiveness (12 weeks follow-up) |
|---|---|---|---|---|
| NRS (scores) | BCP | 6.8±1.5 | 1.8±1.2* | 1.1±1.2* |
| CON | 6.4±1.5 | 4.1±1.1* | 4.4±1.5* | |
| LROM-flexion (mm) | BCP | 17.5±0.6 | 19.5±0.5* | 20.2±0.5* |
| CON | 17.6±1.1 | 18.3±1.0* | 18.8±1.1* | |
| LROM-extension (mm) | BCP | 14.4±0.3 | 13.1±0.6* | 12.7±0.4* |
| CON | 14.4±0.4 | 14.0±0.4* | 14.0±0.5* | |
| RMDQ (scores) | BCP | 16.2±5.3 | 5.9±3.7* | 2.3±2.7* |
| CON | 14.4±6.3 | 11.7±5.9* | 9.9±5.2* |
BCP: Back care pillow group; CON: Control group; SD: Standard deviation; NRS: Numerical rating scale; LROM: Lumbar range of motion; RMDQ: Roland Morris Disability Questionnaire. Values are presented as mean±SD. * Significantly different (p<0.01) from the baseline.